Blakely KM - Search Results

1

Drug-Induced Photosensitivity-An Update: Culprit Drugs, Prevention and Management.

Blakely KM, Drucker AM, Rosen CF. Blakely KM, et al. Drug Saf. 2019 Jul;42(7):827-847. doi: 10.1007/s40264-019-00806-5. Drug Saf. 2019. PMID: 30888626 Review.

2

Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current Literature.

Blakely K, Gooderham M, Papp K. Blakely K, et al. Skin Therapy Lett. 2016 Mar;21(2):1-5. Skin Therapy Lett. 2016. PMID: 27223113 Free article. Review.

3

Management of scalp psoriasis: current perspectives.

Blakely K, Gooderham M. Blakely K, et al. Psoriasis (Auckl). 2016 Mar 29;6:33-40. doi: 10.2147/PTT.S85330. eCollection 2016. Psoriasis (Auckl). 2016. PMID: 29387592 Free PMC article. Review.

4

Early Introduction of Dermatology Clinical Skills in Medical Training.

Blakely K, Bahrani B, Doiron P, Dahlke E. Blakely K, et al. J Cutan Med Surg. 2020 Jan/Feb;24(1):47-54. doi: 10.1177/1203475419882341. Epub 2019 Oct 15. J Cutan Med Surg. 2020. PMID: 31615275

5

A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines.

Vojvodic M, Hansford LM, Morozova O, Blakely KM, Taylor P, Fathers KE, Moffat J, Marra M, Smith KM, Moran MF, Kaplan DR. Vojvodic M, et al. Among authors: blakely km. Curr Drug Discov Technol. 2013 Dec;10(4):283-304. doi: 10.2174/15701638113109990001. Curr Drug Discov Technol. 2013. PMID: 23701117

6

Optimistic honesty: understanding surgeon and patient perspectives on hopeful communication in pancreatic cancer care.

Blakely K, Karanicolas PJ, Wright FC, Gotlib Conn L. Blakely K, et al. HPB (Oxford). 2017 Jul;19(7):611-619. doi: 10.1016/j.hpb.2017.04.001. Epub 2017 May 17. HPB (Oxford). 2017. PMID: 28528268 Free article.

7

FGF23: mediator of poor prognosis in a sizeable subgroup of patients with castration-resistant prostate cancer presenting with severe hypophosphatemia?

Lee EK, Martinez MC, Blakely K, Santos KD, Hoang VC, Chow A, Emmenegger U. Lee EK, et al. Med Hypotheses. 2014 Oct;83(4):482-7. doi: 10.1016/j.mehy.2014.08.005. Epub 2014 Aug 11. Med Hypotheses. 2014. PMID: 25155552

8

Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens.

Smith KM, Datti A, Fujitani M, Grinshtein N, Zhang L, Morozova O, Blakely KM, Rotenberg SA, Hansford LM, Miller FD, Yeger H, Irwin MS, Moffat J, Marra MA, Baruchel S, Wrana JL, Kaplan DR. Smith KM, et al. Among authors: blakely km. EMBO Mol Med. 2010 Sep;2(9):371-84. doi: 10.1002/emmm.201000093. EMBO Mol Med. 2010. PMID: 20721990 Free PMC article.

9

System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma.

Morozova O, Vojvodic M, Grinshtein N, Hansford LM, Blakely KM, Maslova A, Hirst M, Cezard T, Morin RD, Moore R, Smith KM, Miller F, Taylor P, Thiessen N, Varhol R, Zhao Y, Jones S, Moffat J, Kislinger T, Moran MF, Kaplan DR, Marra MA. Morozova O, et al. Among authors: blakely km. Clin Cancer Res. 2010 Sep 15;16(18):4572-82. doi: 10.1158/1078-0432.CCR-10-0627. Epub 2010 Jul 22. Clin Cancer Res. 2010. PMID: 20651058

10

Pooled lentiviral shRNA screening for functional genomics in mammalian cells.

Blakely K, Ketela T, Moffat J. Blakely K, et al. Methods Mol Biol. 2011;781:161-82. doi: 10.1007/978-1-61779-276-2_9. Methods Mol Biol. 2011. PMID: 21877282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page